Common use of Submitting Investigator Clause in Contracts

Submitting Investigator. An investigator who submitted a genomic dataset to an NIH designated data repository (e.g., dbGaP). Study specific DUC addendum phs002295 : Cross-site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms of CIMAC-CIDC Network Public Posting of Genomic Summary Results - Not Allowed. NIH Data Access Committee (DAC) : NCI DAC Important Contacts : XXXXXX@xxxx.xxx.xxx; XXX@xxxx.xxx.xxx In the event of a data management incident, within 24 hours, please contact emails above. Genomic summary results will be available only to CIMAC-CIDC network investigators, trial Principal Investigators IC Specific Access Term : and approved personnel as described by the CIMAC-CIDC guidelines (xxxxx://xxxxx-xxxxxxx.xxx/wp-content/uploads/2019/08/Guidelines-for-CIMAC-CIDC-Aug-20-2019.pdf) Acknowledgement Statement : Scientific and financial supports for the CIMAC-CIDC Network are provided through the National Cancer Institute (NCI) Cooperative Agreements U24CA224319 (to the Icahn School of Medicine at Mount Sinai CIMAC), U24CA224331 (to the Xxxx-Xxxxxx Cancer Institute CIMAC), U24CA224285 (to the University of Texas MD Xxxxxxxx Cancer Center CIMAC), U24CA224309 (to the Stanford University CIMAC), and U24CA224316 (to the CIDC at Xxxx-Xxxxxx Cancer Institute). This work is also supported by grants from the Lung SPORE P50CA070907, NIH CCSG Award (CA016672), MD Xxxxxxxx Cancer Center Support Grant (CA016672), National Cancer Institute under contract HHSN261200800001E. Additional support is made possible through the NCI CTIMS Contract HHSN261201600002C (to the Emmes Company, LLC). Scientific and financial supports for the PACT projects are made possible through funding support provided to the FNIH by: AbbVie Inc., Amgen Inc., Boehringer-Ingelheim Pharma GmbH & Co. KG., Xxxxxxx-Xxxxx Squibb, Celgene Corporation, Genentech Inc, Gilead, GlaxoSmithKline plc, Xxxxxxx Pharmaceutical Companies of Xxxxxxx & Xxxxxxx, Novartis Institutes for Biomedical Research, Pfizer Inc., and Sanofi. Name : General Research Use Consent Group # : 1 Abbreviation : GRU